FDA Import Refusal SCS-0405203-5/11/3 — East India Pharmaceutical
The FDA refused shipment SCS-0405203-5/11/3 from East India Pharmaceutical (India) on Oct 3, 2023. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charges: 118,75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Oct 3, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LCA01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 118,75